The Limitations of Symptom-based Heart Failure Management
Heart failure (HF) has emerged as a global epidemic and it affects about 6 million adults in the US. HF medical treatment, as recommended in guidelines, significantly improves survival and quality of life; however, the mortality burden of HF remains high. For decades, treatment has been guided, main...
Saved in:
| Main Authors: | Lampros Papadimitriou, Charles K Moore, Javed Butler, Robert C Long |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2019-05-01
|
| Series: | Cardiac Failure Review |
| Online Access: | https://www.cfrjournal.com/articles/limitations-symptom-based-heart-failure-management |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heart Failure
by: Gregory Giamouzis, et al.
Published: (2011-01-01) -
Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure
by: Khawaja M. Talha, et al.
Published: (2022-12-01) -
Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
by: Muhammad Shahzeb Khan, et al.
Published: (2019-11-01) -
Assessment of Nutritive Status in Patients with Symptoms of Heart Failure
by: O. Yu. Bastrikov, et al.
Published: (2020-09-01) -
SERELAXIN IN THE STRATEGY OF MANAGEMENT THE PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: FROM DECREASING OF SYMPTOMS TO THE IMPROVEMENT OF SURVIVAL
by: I. V. Zhirov, et al.
Published: (2015-09-01)